Precision BioSciences Inc...

NASDAQ: DTIL · Real-Time Price · USD
4.71
-0.06 (-1.26%)
At close: Aug 15, 2025, 3:59 PM
4.71
-0.11%
After-hours: Aug 15, 2025, 07:51 PM EDT

Precision BioSciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
18K 29K 638K 576K 49.9M 17.58M 7.04M 13.12M 19.79M 8.78M 10.6M 7.36M 3.82M 3.32M 6.34M 24.04M 68.81M 16.35M
Cost of Revenue
696K n/a n/a n/a n/a n/a 1.56M 2.04M 2.38M 2.28M 2.27M 2.25M 2.23M 2.26M n/a n/a n/a n/a
Gross Profit
-678K 29K 638K 576K 49.9M 17.58M 5.48M 11.08M 17.4M 6.5M 8.32M 5.12M 1.59M 1.06M 6.34M 24.04M 68.81M 16.35M
Operating Income
-21.88M -22.11M -24.85M -21.27M 24.15M -4.19M -14.89M -12.36M -11.99M -24.46M -20.55M -22.93M -29.6M -27.35M -30.75M -11.54M 21.63M -18.74M
Interest Income
1.12M 1.32M 1.49M 1.76M 1.84M 1.66M 1.83M 1.87M 1.95M 2.04M 1.94M 1.17M 192K 172K 63K 44K 48K 53K
Pretax Income
-23.52M -20.57M -17.75M -16.43M 32.75M 8.59M -13.43M -12.11M -11.89M -25.06M -28.49M -23.95M -31.04M -28.17M -22.29M -11.28M 21.66M -18.69M
Net Income
-23.52M -20.57M -17.75M -16.43M 32.75M 8.59M -16.29M -8.08M -11.89M -23.56M -36.49M -24.96M -32.47M -28.99M -22.29M -11.28M 21.66M -18.69M
Selling & General & Admin
8.76M 8.55M 9.58M 8.77M 8.53M 8.43M 8.54M 9.63M 9.83M 11.09M 10.07M 10.33M 10.48M 10.69M 10.62M 9.64M 9.94M 9.5M
Research & Development
12.44M 13.59M 15.91M 13.08M 17.23M 13.34M 13.39M 15.85M 21.95M 22.16M 21.07M 19.96M 22.94M 19.97M 26.47M 25.94M 37.23M 25.59M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
21.2M 22.14M 25.48M 21.85M 25.75M 21.77M 21.93M 25.48M 31.78M 33.24M 31.14M 30.29M 33.42M 30.66M 37.09M 35.58M 47.17M 35.09M
Interest Expense
358K 354K 392K 256K 560K 574K 579K 576K 553K 522K 486K 405K 178K 42K 53K 55K 24K n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
21.89M 22.14M 25.48M 21.85M 25.75M 21.77M 21.93M 25.48M 31.78M 33.24M 31.14M 30.29M 33.42M 30.66M 37.09M 35.58M 47.17M 35.09M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a -3.2M -1.5M 8M 1.02M 1.43M 822K 53K 55K 48K n/a
Shares Outstanding (Basic)
11.05M 929.21M 6.83M 7.29M 6.97M 5.06M 4.01M 3.84M 3.8M 3.71M 3.7M 3.69M 2.27M 2.03M 2.03M 1.99M 1.92M 1.89M
Shares Outstanding (Diluted)
11.05M 929.21M 6.88M 7.29M 7.01M 5.06M 4.01M 3.84M 3.8M 3.71M 3.7M 3.69M 2.27M 2.03M 2.03M 1.99M 1.99M 1.89M
EPS (Basic)
-2.13 -0.02 -2.51 -2.25 4.70 1.70 -4.06 -2.1 -3.13 -6.35 -9.87 -6.76 -14.33 -14.25 -10.98 -5.67 11.25 -9.9
EPS (Diluted)
-2.13 -0.02 -2.5 -2.25 4.67 1.70 -4.06 -2.1 -3.13 -6.35 -9.87 -6.76 -14.33 -14.25 -10.98 -5.67 10.86 -9.9
EBITDA
-22.47M -19.51M -16.6M -15.16M 34.69M 10.59M -11.3M -9.5M -95K -22.26M -25.11M -21.29M -28.63M -25.87M -19.74M -8.65M 24.34M -16.22M
EBIT
-23.16M -20.21M -17.35M -16.17M 33.31M 9.16M -12.86M -11.53M -2.48M -24.54M -28M -23.54M -30.86M -28.13M -22.24M -11.22M 21.68M -18.69M
Depreciation & Amortization
696K 705K 757K 1.01M 1.38M 1.43M 1.56M 2.04M 2.38M 2.28M 2.27M 2.25M 2.23M 2.26M 2.49M 2.57M 2.66M 2.47M